Abstract 6658: TcE armed oncolytic virus VSV-GP combines oncolysis and T-cell retargeting for improved efficacy

Aparna Ponnurangam, Nolden Tobias, Charlotte Lempp(Boehringer Ingelheim (Germany)), Peter Groß(Boehringer Ingelheim (Germany)), Sophie Walter(Max Delbrück Center), Theresa Schwaiger(University of Graz), Monika Petersson(Boehringer Ingelheim (Austria)), Wolfgang Rist(University of Applied Sciences Biberach), Krishna Das, Jutta Petschenka(Boehringer Ingelheim (Germany)), Fabian Heinemann(Boehringer Ingelheim (Germany)), Srinath Kasturirangan(Boehringer Ingelheim (France)), Tanja Schoenberger(Boehringer Ingelheim (Germany)), Simone Bartl, Melissa Mayr
Cancer Research
March 22, 2024
Cited by 0


Related Papers